2MG9 image
Deposition Date 2013-10-30
Release Date 2014-04-02
Last Version Date 2024-11-06
Entry Detail
PDB ID:
2MG9
Title:
Truncated EGF-A
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Conformers Calculated:
50
Conformers Submitted:
20
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Low-density lipoprotein receptor
Gene (Uniprot):LDLR
Chain IDs:A
Chain Length:27
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Design and Synthesis of Truncated EGF-A Peptides that Restore LDL-R Recycling in the Presence of PCSK9 In Vitro.
Chem.Biol. 21 284 294 (2014)
PMID: 24440079 DOI: 10.1016/j.chembiol.2013.11.014

Abstact

Disrupting the binding interaction between proprotein convertase (PCSK9) and the epidermal growth factor-like domain A (EGF-A domain) in the low-density lipoprotein receptor (LDL-R) is a promising strategy to promote LDL-R recycling and thereby lower circulating cholesterol levels. In this study, truncated 26 amino acid EGF-A analogs were designed and synthesized, and their structures were analyzed in solution and in complex with PCSK9. The most potent peptide had an increased binding affinity for PCSK9 (KD = 0.6 μM) compared with wild-type EGF-A (KD = 1.2 μM), and the ability to increase LDL-R recycling in the presence of PCSK9 in a cell-based assay.

Legend

Protein

Chemical

Disease

Primary Citation of related structures